244 related articles for article (PubMed ID: 31350965)
21. Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008.
Cuny F; Meunier A; Heutte N; Rame JP; De Raucourt D; Babin E; Blanchard D
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):129-34. PubMed ID: 25838235
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of combined radiotherapy with EGFR inhibitors and chemotherapy for laryngeal organ preservation in patients with locally advanced hypopharyngeal carcinomas.
Zhang X; Wang J; Wu W; Liu M; Zhao F; Du L; Huang D; Yang S; Ma L
Curr Cancer Drug Targets; 2014; 14(6):589-98. PubMed ID: 25039274
[TBL] [Abstract][Full Text] [Related]
23. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
24. [Laryngeal preservation for hypopharyngeal cancer by radiotherapy with S-1 and vitamin A(TAR therapy)].
Nakashima T; Toh S; Shiratsuchi H; Yasumatsu R; Fukushima J; Nakamura K; Shioyama Y; Komune S
Gan To Kagaku Ryoho; 2012 May; 39(5):759-63. PubMed ID: 22584327
[TBL] [Abstract][Full Text] [Related]
25. Optimal sequencing of chemoradiotherapy for locally advanced laryngeal cancer.
Shah NK; Qureshi MM; Dyer MA; Patel SA; Kim K; Everett PC; Grillone GA; Jalisi SM; Truong MT
Laryngoscope; 2019 Oct; 129(10):2313-2320. PubMed ID: 30628077
[TBL] [Abstract][Full Text] [Related]
26. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
27. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
28. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M
Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123
[TBL] [Abstract][Full Text] [Related]
30. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
[TBL] [Abstract][Full Text] [Related]
31. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
32. Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx.
Chen AM; Hsu S; Meshman J; Chin R; Beron P; Abemayor E; St John M
Head Neck; 2017 Jul; 39(7):1322-1326. PubMed ID: 28301066
[TBL] [Abstract][Full Text] [Related]
33. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Int J Clin Oncol; 2015 Dec; 20(6):1081-5. PubMed ID: 25804347
[TBL] [Abstract][Full Text] [Related]
35. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience.
Nakajima A; Nishiyama K; Morimoto M; Nakamura S; Suzuki O; Kawaguchi Y; Miyagi K; Fujii T; Yoshino K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e129-35. PubMed ID: 21640496
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA
J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
[TBL] [Abstract][Full Text] [Related]
38. Hyperfractionated radiation therapy for hypopharyngeal carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survival.
Niibe Y; Karasawa K; Mitsuhashi T; Tanaka Y
Jpn J Clin Oncol; 2003 Sep; 33(9):450-5. PubMed ID: 14594938
[TBL] [Abstract][Full Text] [Related]
39. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
[No Abstract] [Full Text] [Related]
40. Organ preservation surgery for pyriform sinus carcinoma with vocal cord fixation: functional and oncological outcomes.
Xu S; Huang Y; Huang H; Qian J; Wang K; Wu Y; Wang X; Xu Z; Liu S; Liu J
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3611-3617. PubMed ID: 34825265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
